Lipoprotein apheresis aims to substantially reduce high cholesterol levels and other harmful lipoproteins in the patient’s bloodstream by using direct adsorption or filtration technologies. DALI® lipoprotein apheresis is used to treat patients with severe hypercholesterolemia and/or elevated levels of lipoprotein(a) [Lp(a)].
- Highly selective LDL-C and Lp(a) removal
- Significantly effective in the reduction of LDL-C and Lp(a)
- Short treatment time
- Simple treatment procedure